Evercore ISI Reiterates Buy Rating on Krystal Biotech (KRYS), Sets $218 PT

finance.yahoo.com/news/evercore-isi-reiterates-buy-rating-094520918.html

Krystal Biotech, Inc. (NASDAQ:KRYS) is one of the best gene-editing stocks to buy according to hedge funds. On November 5, Evercore ISI’s Gavin Clark-Gartner affirmed a Buy rating on Krystal Biotech, Inc. (NASDAQ:KRYS) stock and set a price target of $218.
In a different update, Krystal…

This story appeared on finance.yahoo.com, 2025-11-18 09:45:20.
The Entire Business World on a Single Page. Free to Use →